Analyst stock forecast
Medline Forecast: $44.54 Analyst Target
Direct answer
Medline's average price target is $44.54.
The target implies +27% from the recorded current price, and the consensus rating is Buy.
The low target implies -3.1%, the high target implies +56.8%, and the range spans 59.9% of the current price.
Forecast evidence checked September 28, 2026.
Get free Medline email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $35.07
- Average price target
- $44.54
- High price target
- $55.00
- Low price target
- $34.00
- Low target gap
- -3.1%
- Target upside
- +27%
- High target gap
- +56.8%
- Target range width
- 59.9%
- Consensus rating
- Buy
- Analysts
- 26
- Evidence date
- September 28, 2026
- Valid through
- October 5, 2026
Explore related company data
Read the frequently asked questions.
What is Medline's average price target?
Medline's verified average price target is $44.54. The target range is $34.00 to $55.00.
How far are Medline's low and high targets from the recorded price?
The low target implies -3.1%, while the high target implies +56.8%.
How many analysts are included in Medline's consensus?
The verified consensus includes 26 analysts.
How is Medline's target upside or downside calculated?
The average target of $44.54 is divided by the recorded price of $35.07, then one is subtracted to produce +27%. This does not guarantee a future return.
When was Medline's analyst forecast verified?
The data was verified on 2026-09-28. The dataset is valid through 2026-10-05.